Adverse events1,183

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

141 to 160 of 1,183

Type	Event	Organ system	Group	Affected	At risk
other	Dyspepsia	Gastrointestinal disorders	Midostaurin: Part 1 (Japan Only) (On-treatment)	0	5
other	Dyspepsia	Gastrointestinal disorders	Midostaurin: Part 2 (On-treatment)	1	30
other	Dyspepsia	Gastrointestinal disorders	Placebo Part 2 (On-treatment)	2	31
other	Dyspepsia	Gastrointestinal disorders	Midostaurin: Part 1 (Japan Only) (Post-treatment Survival Follow-up)		0
other	Dyspepsia	Gastrointestinal disorders	Midostaurin: Part 2 (Post-treatment Survival Follow-up)		0
other	Dyspepsia	Gastrointestinal disorders	Placebo: Part 2 (Post-treatment Survival Follow-up)		0
other	Dyspepsia	Gastrointestinal disorders	Other Participants		0
other	Gastrointestinal disorder	Gastrointestinal disorders	Midostaurin: Part 1 (Japan Only) (On-treatment)	0	5
other	Gastrointestinal disorder	Gastrointestinal disorders	Midostaurin: Part 2 (On-treatment)	2	30
other	Gastrointestinal disorder	Gastrointestinal disorders	Placebo Part 2 (On-treatment)	0	31
other	Gastrointestinal disorder	Gastrointestinal disorders	Midostaurin: Part 1 (Japan Only) (Post-treatment Survival Follow-up)		0
other	Gastrointestinal disorder	Gastrointestinal disorders	Midostaurin: Part 2 (Post-treatment Survival Follow-up)		0
other	Gastrointestinal disorder	Gastrointestinal disorders	Placebo: Part 2 (Post-treatment Survival Follow-up)		0
other	Gastrointestinal disorder	Gastrointestinal disorders	Other Participants		0
other	Gastrointestinal haemorrhage	Gastrointestinal disorders	Midostaurin: Part 1 (Japan Only) (On-treatment)	0	5
other	Gastrointestinal haemorrhage	Gastrointestinal disorders	Midostaurin: Part 2 (On-treatment)	0	30
other	Gastrointestinal haemorrhage	Gastrointestinal disorders	Placebo Part 2 (On-treatment)	2	31
other	Gastrointestinal haemorrhage	Gastrointestinal disorders	Midostaurin: Part 1 (Japan Only) (Post-treatment Survival Follow-up)		0
other	Gastrointestinal haemorrhage	Gastrointestinal disorders	Midostaurin: Part 2 (Post-treatment Survival Follow-up)		0
other	Gastrointestinal haemorrhage	Gastrointestinal disorders	Placebo: Part 2 (Post-treatment Survival Follow-up)		0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous page Next page

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03280030/events?page=8

API reference For AI assistants